We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BMS’s Opdivo Clinical Trial Shows Promise

News   Apr 19, 2016

 
BMS’s Opdivo Clinical Trial Shows Promise
 
 
 

RELATED ARTICLES

First Ever Video of T Cell "Safety Training"

News

Immunologists have captured on video what happens when T-cells – the contract killers of the immune system – undergo a type of assassin-training program before they get unleashed in the body.

READ MORE

Flu Virus’ Best Friend: Low Humidity

News

Yale researchers have pinpointed a key reason why people are more likely to get sick and even die from flu during winter months: low humidity.

READ MORE

Antibody Agents Could Treat Multitude of Blood and Immune Disorders

News

An antibody to a protein on blood-forming stem cells may allow bone marrow transplants without the need for chemotherapy and radiation, according to a Stanford study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE